Inovio Pharmaceuticals
INO
#9034
Rank
ยฃ89.17 M
Marketcap
ยฃ1.30
Share price
-3.87%
Change (1 day)
-11.09%
Change (1 year)

Inovio Pharmaceuticals (INO) - Total debt

Total debt on the balance sheet as of September 2025 : ยฃ7.47 Million

According to Inovio Pharmaceuticals's latest financial reports the company's total debt is ยฃ7.47 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Inovio Pharmaceuticals - Total debt on balance sheet (from 1998 to 2025)

Total debt by year

Year Total debt Change
2024-12-31ยฃ9.45 M-60.13%
2023-12-31ยฃ23.71 M-10.56%
2022-12-31ยฃ26.51 M8.37%
2021-12-31ยฃ24.46 M-14.6%
2020-12-31ยฃ28.64 M-62.25%
2019-12-31ยฃ75.88 M
2018-12-31N/A
2010-12-31N/A-100%
2009-12-31ยฃ7.48 M-9.39%
2008-12-31ยฃ8.26 M
2003-12-31ยฃ0.18 M1338.03%
2002-12-31ยฃ0.01 M-61.21%
2001-12-31ยฃ0.03 M
2001-03-31ยฃ0.08 M11.74%
2000-03-31ยฃ0.07 M19.96%
1999-03-31ยฃ0.06 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
ยฃ35.75 B 478,263.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ26.38 B 352,946.85%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
ยฃ45.38 B 607,153.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
ยฃ18.60 B 248,807.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ30.86 B 412,805.93%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
ยฃ17.79 B 238,038.96%๐Ÿ‡ฌ๐Ÿ‡ง UK
Cleveland BioLabs
CBLI
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
ยฃ0.23 B 3,021.35%๐Ÿ‡บ๐Ÿ‡ธ USA